CardioVascular BioTherapeutics, Inc. Contracts & Agreements
54 Contracts & Agreements
- Business Finance (14 contracts)
- Business Formation (2)
- Business Operations (7)
- Intellectual Property (5)
- Real Estate (7)
- Uncategorized (19)
- DEVELOPMENT AGREEMENT BETWEEN CARDIOVASCULAR BIOTHERAPEUTICS, INC. AND CARDIO NEO-GENESIS LP Dated as of November 11, 2008 Exhibit 10.1 TABLE OF CONTENTS (Filed With SEC on November 14, 2008)
- TECHNOLOGY LICENSE AGREEMENT BETWEEN CARDIOVASCULAR BIOTHERAPEUTICS, INC. AND CARDIO NEO-GENESIS, LP Dated as of November 11, 2008 Exhibit 10.2 (Filed With SEC on November 14, 2008)
- Cardio Neo-Genesis Limited Partnership Sponsorship Agreement (Filed With SEC on November 14, 2008)
- DEVELOPMENT AGREEMENT BETWEEN CARDIOVASCULAR BIOTHERAPEUTICS, INC. AND PRODERM, LP Dated as of July 8, 2008 TABLE OF CONTENTS (Filed With SEC on July 18, 2008)
- TECHNOLOGY LICENSE AGREEMENT BETWEEN CARDIOVASCULAR BIOTHERAPEUTICS, INC. AND PRODERM, LP Dated as of July 8, 2008 TABLE OF CONTENTS (Filed With SEC on July 18, 2008)
- ProDerm Limited Partnership (Filed With SEC on July 18, 2008)
- TECHNOLOGY LICENSE AGREEMENT BETWEEN CARDIOVASCULAR BIOTHERAPEUTICS, INC. AND CARDIO DERMA CLINICAL PARTNERS, LP Dated as of July 10, 2008 TABLE OF CONTENTS (Filed With SEC on July 18, 2008)
- AMENDMENT II to FIRMINVEST AG COMMITMENT LETTER (Filed With SEC on November 16, 2007)
- COMMON STOCK PURCHASE WARRANT For the Purchase of 3,700,000 Shares of Common Stock, $0.001 Par Value of CARDIOVASCULAR BIOTHERAPEUTICS, INC. (A Delaware Corporation) (Filed With SEC on November 16, 2007)
- CARDIOVASCULAR BIOTHERAPEUTICS, INC. SUBSCRIPTION AGREEMENT (Filed With SEC on November 16, 2007)
- AMENDMENT to FIRMINVEST AG COMMITMENT LETTER (Filed With SEC on August 17, 2007)
- AGREEMENT EXCHANGING LEASE GUARANTIES (Filed With SEC on May 29, 2007)
- Postfach 1718 Stockerstrasse 48 8027 Zürich Telefon +41 44 288 36 36 Fax +41 44 288 36 11 (Filed With SEC on May 25, 2007)
- JOINT PATENT AGREEMENT February 28, 2007 (Filed With SEC on March 29, 2007)
- FIRST AMENDMENT TO LEASE (Filed With SEC on September 14, 2006)
- SECOND AMENDMENT (Filed With SEC on September 6, 2006)
- FIRST AMENDMENT (Filed With SEC on September 6, 2006)
- LEASE by and between BMR-6828 NANCY RIDGE DRIVE LLC, a Delaware limited liability company and (Filed With SEC on August 11, 2006)
- AMENDED AND RESTATED JOINT PATENT OWNERSHIP AND LICENSE AGREEMENT (Filed With SEC on May 26, 2006)
- PLAZA WEST SUMMERLIN LAS VEGAS, NEVADA LEASE AGREEMENT (Filed With SEC on March 31, 2006)
- CARDIOVASCULAR BIOTHERAPEUTICS, INC. SUBLEASE AGREEMENT (Filed With SEC on March 31, 2006)
- SECURITIES PURCHASE AGREEMENT (Filed With SEC on March 22, 2006)
- REGISTRATION RIGHTS AGREEMENT (Filed With SEC on March 22, 2006)
- SECURITY AGREEMENT (Filed With SEC on March 22, 2006)
- PATENT SECURITY AGREEMENT (Filed With SEC on March 22, 2006)
- GUARANTY (Filed With SEC on March 22, 2006)
- PLEDGE AGREEMENT (Filed With SEC on March 22, 2006)
- FORM OF NOTE (Filed With SEC on March 22, 2006)
- FORM OF INITIAL WARRANT (Filed With SEC on March 22, 2006)
- FORM OF REPURCHASE WARRANT (Filed With SEC on March 22, 2006)
- GUARANTY (Filed With SEC on March 22, 2006)
- STANDARD INDUSTRIAL NET LEASE (Filed With SEC on March 21, 2006)
- INDEMNITY AND REIMBURSEMENT AGREEMENT (Filed With SEC on March 21, 2006)
- CARDIOVASCULAR BIOTHERAPEUTICS, INC. 1,500,000 Shares (Filed With SEC on February 4, 2005)
- CARDIOVASCULAR BIOTHERAPEUTICS, INC. 2,000,000 Shares (Filed With SEC on January 31, 2005)
- VOTING AGREEMENT AND PROXY (Filed With SEC on January 31, 2005)
- THETRANSFER OF THIS WARRANT IS RESTRICTED AS DESCRIBED HEREIN. CARDIOVASCULAR BIOTHERAPEUTICS, INC. Warrant for the Purchase of Shares of Common Stock, par value $.001 per Share (Filed With SEC on January 13, 2005)
- [LETTERHEAD OF MPI RESEARCH] SERVICES AGREEMENT ADDENDUM No. 1 (Filed With SEC on January 13, 2005)
- [LETTERHEAD OF MPI RESEARCH] SERVICES AGREEMENT ADDENDUM No. 2 (Filed With SEC on January 13, 2005)
- AGREEMENT on TECHNOLOGY & BUSINESS RIGHT TRANSFER between Cardio Vascular Genetic Engineering Inc. (a Delaware Corporation) (Filed With SEC on November 26, 2004)
- DaVinci Biomedical research Prod. PROTOCOL ACTIVITY INVOLVING VERTEBRATE ANIMAL MODELS Cardiotoxicity Study of Fibroblast Growth Factor (FGF-1) in Dogs DaVinci Study Number: DB-19 (Filed With SEC on November 26, 2004)
- DaVinci Biomedical research Prod. PROTOCOL Theeffect of Acidic Fibroblast Growth Factor on the outcome of Cerebral Ischemia in the Rat (Filed With SEC on November 26, 2004)
- DaVinci Biomedical research Prod. PROTOCOL TheEffect of Acidic Fibroblast Growth Factor on the Outcome of Hindlimb Ischemia in the Rat (Filed With SEC on November 26, 2004)
- MASTER AGREEMENT by and between MPI RESEARCH, INC. (hereinafter referred to as MPI) Mattawan, Michigan (Filed With SEC on November 26, 2004)
- SERVICE AGREEMENT (Filed With SEC on November 26, 2004)
- JOINT PATENT OWNERSHIP AND LICENSE AGREEMENT (Filed With SEC on September 23, 2004)
- EXHIBIT 10.3 (Filed With SEC on September 23, 2004)
- EXHIBIT 10.5 (Filed With SEC on September 23, 2004)
- TENANTS ASSIGNMENT OF LEASE WITH CONSENT BY LANDLORD AND ASSUMPTION BY ASSIGNEE (Filed With SEC on September 23, 2004)
- EXHIBIT D GUARANTY OFSUBLEASE (Filed With SEC on September 23, 2004)
- DISTRIBUTORSHIP AGREEMENT (Filed With SEC on September 23, 2004)
- Exhibit 10.9 CLINICAL RESEARCH SERVICES AGREEMENT (Filed With SEC on September 23, 2004)
- Exhibit 10.10 (Filed With SEC on September 23, 2004)
- Exhibit 10.11 Catheter and Disposables Technology Inc., A division of CardioTech International 13845 Industrial Park Blvd., Plymouth, MN 55441 Phone: 763 ###-###-#### Fax: 763... (Filed With SEC on September 23, 2004)
